EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 3.0

Pharmacokinetic Comparison Between a Fixed-Dose Combination of Atorvastatin/Omega-3-Acid Ethyl Esters and the Corresponding Loose Combination in Healthy Korean Male Subjects

Juyoung Khwarg iD, Soyoung Lee iD, In-Jin Jang iD, Won-Ho Kang, Hye Jung Lee, Kyu Yeon Kim iD, Ki-Sun Jeong iD, Chongho Won, Youn Woong Choi, Dae Chul Ha, RaeHoon Jung, Min-Gu Han und 5 weitere

Drug Design, Development and Therapy · 2024

DOI: 10.2147/dddt.s435885 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Drug Design, Development and Therapy, 2024. Verfasst von Juyoung Khwarg und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Eicosapentaenoic Acid, Dyslipidemias. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Eicosapentaenoic AcidDyslipidemiasHumansMaleAtorvastatinHealthy VolunteersCross-Over StudiesDocosahexaenoic AcidsRepublic of KoreaDrug CombinationsArea Under Curve

Stichwörter der Autor:innen

cardiovascular diseasepharmacokinetics

Substanzen

AtorvastatinEicosapentaenoic AcidDocosahexaenoic AcidsDrug Combinations

Autor:innen und Institutionen

  • Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
  • Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, Republic of Korea.
  • R&D Center, Korea United Pharm. Inc., Seoul, Republic of Korea.
  • Caleb Multilab, Inc., Seoul, Republic of Korea.
  • R&D Center, Korea United Pharm.Inc., Sejong, Republic of Korea.
  • Global R&D, Korea United Pharm. Inc., Seoul, Republic of Korea.

ORCID-Profile: Juyoung Khwarg, Soyoung Lee, In-Jin Jang, Kyu Yeon Kim, Ki-Sun Jeong, Kyung-Sang Yu, Jaeseong Oh

Zitieren

APA

Khwarg, J., Lee, S., Jang, I. J., Kang, W. H., Lee, H. J., Kim, K. Y., Jeong, K. S., Won, C., Choi, Y. W., Ha, D. C., Jung, R., Han, M. G., Jung, W. T., Nam, K. Y., Kim, Y., Yu, K. S., & Oh, J. (2024). Pharmacokinetic Comparison Between a Fixed-Dose Combination of Atorvastatin/Omega-3-Acid Ethyl Esters and the Corresponding Loose Combination in Healthy Korean Male Subjects. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s435885

Vancouver

Khwarg J, Lee S, Jang IJ, Kang WH, Lee HJ, Kim KY, et al. Pharmacokinetic Comparison Between a Fixed-Dose Combination of Atorvastatin/Omega-3-Acid Ethyl Esters and the Corresponding Loose Combination in Healthy Korean Male Subjects. Drug Design, Development and Therapy. 2024. doi:10.2147/dddt.s435885

BibTeX
@article{Khwarg2024,
  author = {Khwarg, Juyoung and Lee, Soyoung and Jang, In-Jin and Kang, Won-Ho and Lee, Hye Jung and Kim, Kyu Yeon and Jeong, Ki-Sun and Won, Chongho and Choi, Youn Woong and Ha, Dae Chul and Jung, RaeHoon and Han, Min-Gu and Jung, Won Tae and Nam, Kyu-Yeol and Kim, YeSeul and Yu, Kyung-Sang and Oh, Jaeseong},
  title = {Pharmacokinetic Comparison Between a Fixed-Dose Combination of Atorvastatin/Omega-3-Acid Ethyl Esters and the Corresponding Loose Combination in Healthy Korean Male Subjects},
  journal = {Drug Design, Development and Therapy},
  year = {2024},
  doi = {10.2147/dddt.s435885}
}
Kostenlos starten →